IOL CHEMICALS & PHARM. | ERIS LIFESCIENCES | IOL CHEMICALS & PHARM./ ERIS LIFESCIENCES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 12.4 | 30.2 | 41.0% | View Chart |
P/BV | x | 1.4 | 5.2 | 27.0% | View Chart |
Dividend Yield | % | 1.1 | 0.9 | 126.6% |
IOL CHEMICALS & PHARM. ERIS LIFESCIENCES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
ERIS LIFESCIENCES Mar-23 |
IOL CHEMICALS & PHARM./ ERIS LIFESCIENCES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 750 | 71.6% | |
Low | Rs | 272 | 551 | 49.4% | |
Sales per share (Unadj.) | Rs | 377.6 | 123.9 | 304.8% | |
Earnings per share (Unadj.) | Rs | 23.7 | 27.5 | 86.1% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 36.1 | 87.4% | |
Dividends per share (Unadj.) | Rs | 4.00 | 7.35 | 54.4% | |
Avg Dividend yield | % | 1.0 | 1.1 | 87.5% | |
Book value per share (Unadj.) | Rs | 256.8 | 161.3 | 159.2% | |
Shares outstanding (eoy) | m | 58.71 | 135.99 | 43.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 5.2 | 20.4% | |
Avg P/E ratio | x | 17.1 | 23.6 | 72.2% | |
P/CF ratio (eoy) | x | 12.8 | 18.0 | 71.2% | |
Price / Book Value ratio | x | 1.6 | 4.0 | 39.0% | |
Dividend payout | % | 16.9 | 26.7 | 63.2% | |
Avg Mkt Cap | Rs m | 23,743 | 88,446 | 26.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 3,462 | 48.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 16,851 | 131.6% | |
Other income | Rs m | 256 | 112 | 229.6% | |
Total revenues | Rs m | 22,427 | 16,963 | 132.2% | |
Gross profit | Rs m | 2,257 | 5,369 | 42.0% | |
Depreciation | Rs m | 462 | 1,171 | 39.4% | |
Interest | Rs m | 165 | 263 | 62.5% | |
Profit before tax | Rs m | 1,887 | 4,046 | 46.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 305 | 162.4% | |
Profit after tax | Rs m | 1,391 | 3,742 | 37.2% | |
Gross profit margin | % | 10.2 | 31.9 | 31.9% | |
Effective tax rate | % | 26.2 | 7.5 | 348.4% | |
Net profit margin | % | 6.3 | 22.2 | 28.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 8,427 | 114.7% | |
Current liabilities | Rs m | 5,025 | 5,212 | 96.4% | |
Net working cap to sales | % | 20.9 | 19.1 | 109.7% | |
Current ratio | x | 1.9 | 1.6 | 119.0% | |
Inventory Days | Days | 43 | 15 | 290.1% | |
Debtors Days | Days | 8 | 63 | 13.1% | |
Net fixed assets | Rs m | 11,017 | 26,287 | 41.9% | |
Share capital | Rs m | 587 | 136 | 431.7% | |
"Free" reserves | Rs m | 14,490 | 21,796 | 66.5% | |
Net worth | Rs m | 15,077 | 21,932 | 68.7% | |
Long term debt | Rs m | 0 | 6,444 | 0.0% | |
Total assets | Rs m | 20,684 | 34,713 | 59.6% | |
Interest coverage | x | 12.5 | 16.4 | 76.1% | |
Debt to equity ratio | x | 0 | 0.3 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.5 | 220.8% | |
Return on assets | % | 7.5 | 11.5 | 65.2% | |
Return on equity | % | 9.2 | 17.1 | 54.1% | |
Return on capital | % | 13.6 | 15.2 | 89.6% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0.5 | 0.0% | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | 78 | 0.0% | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 5,327 | 113.6% | |
Net fx | Rs m | -122 | -5,327 | 2.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 2,917 | 41.9% | |
From Investments | Rs m | -1,200 | -9,821 | 12.2% | |
From Financial Activity | Rs m | -41 | 6,880 | -0.6% | |
Net Cashflow | Rs m | -18 | 52 | -35.7% |
Indian Promoters | % | 48.2 | 54.9 | 87.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 2.5 | 27.7 | 9.2% | |
FIIs | % | 2.2 | 13.1 | 16.6% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 45.1 | 114.9% | |
Shareholders | 134,235 | 46,496 | 288.7% | ||
Pledged promoter(s) holding | % | 0.0 | 11.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | ERIS LIFESCIENCES | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.31% | 0.02% | 1.18% |
1-Month | -9.26% | -3.76% | -0.75% |
1-Year | 29.97% | 46.86% | 61.82% |
3-Year CAGR | -13.41% | 11.33% | 18.16% |
5-Year CAGR | 13.41% | 5.62% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the ERIS LIFESCIENCES share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of ERIS LIFESCIENCES the stake stands at 54.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of ERIS LIFESCIENCES.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
ERIS LIFESCIENCES paid Rs 7.4, and its dividend payout ratio stood at 26.7%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of ERIS LIFESCIENCES.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.